Welcome to our dedicated page for Hanover Insuranc SEC filings (Ticker: THG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hanover Insurance Group, Inc. (NYSE: THG) is an SEC-reporting holding company for several property and casualty insurance subsidiaries. This page provides access to the company’s U.S. Securities and Exchange Commission filings, which document its regulatory and financial reporting as a public insurer. These filings are a primary source for understanding The Hanover’s capital structure, debt issuance, financial results, and other material events.
Among the key documents are current reports on Form 8-K, where The Hanover discloses significant developments. Recent 8-K filings describe the issuance of senior unsecured notes due 2035, the planned use of proceeds to repay existing debentures and notes and for general corporate purposes, and the call for redemption of 4.500% notes due 2026. Another 8-K furnishes the company’s quarterly financial results and references an accompanying financial supplement made available on its website.
Filings also include a Form 25 submitted by the New York Stock Exchange relating to the removal from listing and registration of a specific class of 7 5/8% senior debentures due 2025. The same filing identifies The Hanover’s common stock as listed on the New York Stock Exchange under the symbol THG. Together, these documents outline how the company manages its publicly traded securities and complies with exchange and SEC requirements.
On Stock Titan, investors can use AI-powered tools to review these filings, with real-time updates from EDGAR and summaries that explain the significance of items such as 8-K disclosures and Form 25 notices. This helps users quickly understand how The Hanover reports its financial condition, capital actions, and other material information within the regulatory framework for U.S. public companies.
Hanover Insurance Group executive Denise Lowsley disposed of 1,207 shares of common stock to cover taxes on vested restricted stock units. The shares were forfeited at $180.63 per share on February 27, 2026, and she now directly holds 4,932.24 shares.
Hanover Insurance Group executive vice president Lee Willard T reported a tax-related share disposition. On February 27, 2026, 1,215 shares of common stock were forfeited at $180.63 per share to cover withholding taxes upon vesting of previously granted restricted stock units. After this tax-withholding disposition, he directly owns 6,968.851 common shares.
Hanover Insurance Group executive Jeffrey M. Farber reported multiple equity awards tied to the company’s long-term incentive plan. On February 24, 2026, he acquired 14,436 stock options at an exercise price of $0.0000 per share.
He also acquired 5,043, 3,250 and 3,025 shares of common stock through performance-based and time-based restricted stock units granted under the 2022 Long-Term Incentive Plan. Certain performance-based awards had their performance conditions certified and are scheduled to vest on February 27, 2026.
Hanover Insurance Group Executive Vice President Dennis Francis Kerrigan reported equity awards under the company’s long-term incentive plans. On February 24, 2026, he acquired 5,328 stock options with an exercise price of $0.0000 per share and 1,730 shares of common stock at no cost.
He also received additional common stock awards of 1,115 shares and 1,117 shares, each reported as grants or other acquisitions, bringing his direct common stock holdings to 13,719.585 shares. Footnotes indicate that related performance-based and restricted stock unit awards vest over multi‑year periods, with some vesting on February 27, 2026, and options vesting in thirds on each of the first three anniversaries of grant.
Hanover Insurance Group Executive Vice President Richard W. Lavey reported multiple equity awards tied to the company’s 2022 Long-Term Incentive Plan. On February 24, 2026, he acquired 9,968 stock options at an exercise price of $0.00 per share and several stock-based awards totaling 6,828 common shares at no cost.
The stock awards reflect performance-based restricted stock units whose performance conditions were certified at 150% and 100% of target, plus a time-based restricted stock unit grant. The performance-based awards are scheduled to vest on February 27, 2026, while other units and options vest over a three-year period.
HANOVER INSURANCE GROUP, INC. Executive Vice President David John Lovely reported equity awards rather than open‑market trades. On February 24, 2026, he acquired a stock option for 3,781 shares at a grant price of $0.00 per share and several stock grants also at no cost.
The filing shows three separate common stock awards of 1,082, 698, and 793 shares, all recorded as grants or awards. Footnotes explain these awards relate to performance‑based and time‑based restricted stock units under the company’s 2022 Long‑Term Incentive Plan, with vesting tied to February 27, 2026 or later anniversaries.
Hanover Insurance Group Executive Vice President Denise Lowsley reported equity awards and vesting-related share grants. On February 24, 2026, she was granted a stock option for 3,094 shares of common stock, which vests in three equal annual installments from the grant date.
She also acquired 1,154 restricted stock units that vest on the third anniversary of grant. In addition, performance-based restricted stock unit awards granted in 2023 had their performance conditions certified, resulting in 744 shares tied to a 150% performance outcome and 649 shares tied to a 100% performance outcome, both still subject to time-based vesting through February 27, 2026.
Roche John C reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. President and CEO John C. Roche reported equity awards tied to the company’s long-term incentive plan. He received an option to buy 45,025 shares of common stock, plus stock-based awards totaling 31,229 shares at no cash cost to him.
Footnotes explain that these grants reflect performance-based restricted stock units from a 2023 award, with performance certified at 150% and 100% of target and vesting on February 27, 2026, as well as new restricted stock units and options that generally vest over three years.
Hanover Insurance Group Executive Vice President Salvatore Bryan J reported equity awards and vesting-related acquisitions of company stock and options. On February 24, 2026, he received a grant of 8,937 common stock options at a price of $0 per share.
He also acquired common shares through performance-based restricted stock units and restricted stock units. These include awards of 2,595, 1,672, and 1,873 common shares, all at $0 per share. Two PBRSU awards granted in 2023 had their performance conditions certified at 150% and 100% of target and remain subject to time-based vesting until February 27, 2026. A separate RSU grant vests on the third anniversary of grant, and the options vest in three equal annual installments.
Hanover Insurance Group Executive Vice President T. Willard Lee reported equity awards under the company’s 2022 Long-Term Incentive Plan. On February 24, 2026, he acquired 3,781 stock options with an exercise right described as a common stock option. These options vest in three equal annual installments on each of the first three anniversaries of the grant date.
On the same date, he also acquired a total of 2,691 shares or units of common stock at no cost in multiple grants. Footnotes explain that earlier performance-based restricted stock units granted on February 27, 2023 had performance conditions certified at 150% and 100% of target, with all such awards remaining subject to time-based vesting and scheduled to vest on February 27, 2026, while another restricted stock unit grant vests on its third anniversary.